Singapore - English - HSA (Health Sciences Authority)

qiagen singapore pte. ltd. - microbiology - the artus hbv qs-rgq kit is an in vitro nucleic acid amplification test for the quantitation of hepatitis b virus (hbv) dna in human edta plasma. this diagnostic test kit utilizes the polymerase chain reaction (pcr) and is configured for use with the qiasymphony sp/as and rotor-gene q instruments. the artus hbv qs-rgq kit is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiviral treatment as measured by changes in human edta plasma hbv dna levels. the artus hbv qs-rgq kit is not intended to be used as a screening test for hbv or as a diagnostic test to confirm the presence of hbv infection.

Singapore - English - HSA (Health Sciences Authority)

qiagen singapore pte. ltd. - microbiology - the artus hcv qs-rgq kit is an in vitro nucleic acid amplification test for the quantitation of hepatitis c virus (hcv) rna in human edta plasma. this diagnostic test kit utilizes the reverse transcription polymerase chain reaction (rt-pcr) and is configured for use with the qiasymphony sp/as and rotor-gene q instruments. the artus hcv qs-rgq kit is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiviral treatment as measured by changes in human edta plasma hcv rna levels. the artus hcv qs-rgq kit is not intended to be used as a screening test for hcv or as a diagnostic test to confirm the presence of hcv infection.

Singapore - English - HSA (Health Sciences Authority)

qiagen singapore pte. ltd. - microbiology - the artus hi virus-1 qs-rgq kit is an in vitro nucleic acid amplification test for the quantitation of human immunodeficiency virus type 1 (hiv-1) rna in human edta plasma. this diagnostic test kit utilizes the reverse transcription polymerase chain reaction (rt-pcr) and is configured for use with the qiasymphony sp/as and rotor-gene q instruments. plasma samples containing group m subtypes a–h have been validated for use in the assay. the artus hi virus-1 qs-rgq kit is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in human edta plasma hiv-1 rna levels. the artus hi virus-1 qs rgq kit is not intended to be used as a screening test for hiv or as a diagnostic test to confirm the presence of hiv infection.

Singapore - English - HSA (Health Sciences Authority)

qiagen singapore pte. ltd. - pathology - the artus hsv-1/2 qs-rgq kit is an in vitro nucleic acid amplification test for the qualitative detection of human herpes simplex virus 1 and 2 dna from human cerebrospinal fluid (csf) and plasma. this diagnostic test kit utilizes the polymerase chain reaction (pcr) and is configured for use with the qiasymphony sp/as and rotor-gene q instruments.

Singapore - English - HSA (Health Sciences Authority)

qiagen singapore pte. ltd. - pathology - the artus vzv qs-rgq kit is an in vitro nucleic acid amplification test for the quantitation of vzv dna in human edta plasma and csf. this diagnostic test kit utilizes the polymerase chain reaction (pcr) and is configured for use with the qiasymphony sp/as and rotor-gene q instruments. this kit is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis.

Singapore - English - HSA (Health Sciences Authority)

qiagen singapore pte. ltd. - pathology - the artus cmv qs-rgq kit is an in vitro nucleic acid amplification test for the quantitation of cytomegalovirus (cmv) dna in human edta plasma and whole blood samples. this diagnostic test kit utilizes the polymerase chain reaction (pcr) and is configured for use with the qiasymphony sp/as and rotor-gene q instruments. the artus cmv qs-rgq kit is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis.

Singapore - English - HSA (Health Sciences Authority)

e-xclusif medical supply pte. ltd. - general hospital - derma+flex® qs™ is intended for topical application only to hold closed easily approximated skin edges of wounds from surgical incisions, including incisions from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. derma+flex® qs™ may be used in conjunction with, but not in place of, deep dermal sutures.

Philippines - English - FDA (Food And Drug Administration)

talan haplacious herbal manufacturer - methyl salicylate,camphor,menthol,eucalyptus oil,herbal extract,mineral oil - liniment - 7 g / 7 g / 5 g / 1 g / qs

United States - English - NLM (National Library of Medicine)

bayer healthcare, llc animal health division - florfenicol (unii: 9j97307y1h) (florfenicol - unii:9j97307y1h) - florfenicol 300 mg in 1 ml - loncor™ 300 is indicated for treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , and histophilus somni , and for the treatment of bovine interdigital phlegmon (foot rot, acute interdigital necrobacillosis, infectious pododermatitis) associated with fusobacterium necrophorum and bacteroides melaninogenicus . also, it is indicated for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica , pasteurella multocida , and histophilus somni . do not use in animals that have shown hypersensitivity to florfenicol. this product contains materials that can be irritating to skin and eyes. avoid direct contact with skin, eyes, and clothing. in case of accidental eye exposure, flush with water for 15 minutes. in case of accidental skin exposure, wash with soap and water. remove contaminated clothing. consult a physician if irritation persists. accidental injection of this product may cause local irritatio

United States - English - NLM (National Library of Medicine)

bausch health us llc - isoproterenol hydrochloride (unii: dia2a74855) (isoproterenol - unii:l628tt009w) - isoproterenol hydrochloride 0.2 mg in 1 ml - isuprel is indicated: isuprel is contraindicated in patients with: risk summary there is no information regarding the presence of isoproterenol in milk or the effects of isoproterenol on the breastfed infant or on milk production. however, due to its short half-life, isoproterenol exposure is expected to be very low in the breastfed infant. safety and efficacy of isoproterenol in pediatric patients have not been established. intravenous infusions of isoproterenol in refractory asthmatic children at rates of 0.05‑2.7 µg/kg/min have caused clinical deterioration, myocardial necrosis, congestive heart failure and death. the risks of cardiac toxicity appear to be increased by some factors [acidosis, hypoxemia, coadministration of corticosteroids, coadministration of methylxanthines (theophylline, theobromine) or aminophylline] that are especially likely to be present in these patients. if i.v. isoproterenol is used in children with refractory asthma, patient monitoring must include continuous assessment of vital